Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma-Reference-Cited by-同舟云学术

Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma

Published:2020-03-27 Issue:13 Volume:26 Page:3443-3454
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Alrasheed Nouf,Lee Lydia,Ghorani Ehsan,Henry Jake Y.,Conde Lucia,Chin Melody,Galas-Filipowicz Daria,Furness Andrew J.S.,Chavda Selina J.,Richards Huw,De-Silva Dunnya,Cohen Oliver C.,Patel Dominic^ORCID,Brooks Anthony,Rodriguez-Justo Manuel,Pule Martin,Herrero Javier^ORCID,Quezada Sergio A.,Yong Kwee L.^ORCID

Funder

Medical Research Council

Cancer Research UK

CITACRUKCRUK

CRUK

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates on CAR T cell therapy in multiple myeloma;Biomarker Research;2024-09-12

2. Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial;Nature Cancer;2024-08-26

3. Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment;Frontiers in Oncology;2024-07-17

4. Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma;Clinical Cancer Research;2024-07-11

5. Current progress of CAR-T-cell therapy for patients with multiple myeloma;International Journal of Hematology;2024-05-23